# MatPlotLib-Challenge---Module-5

Pymaceuticals, Inc. is a new pharmaceutical company that specializes in anti-cancer medications. We have recently began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.

As a senior data analyst at the company, our most recent animal study observed 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.

See the analysis the technical report of the clinical study with top-level summary of the study results.
